22nd Century Group Inc (XXII)

[strut1702]

Gary, what exactly are you trying to covey? I don't understand your position with XXII (see post history).

-Did you sell? Are you holding?

-Are you claiming XXII isn't worth what it's presently valued?

-What do you mean patents can take decades to manifest? What are you referring to?

As stated, many biotechs trade at much higher valuations with 0 revenues with IP in clinical trials and many years from potential FDA approval / monetization. I would argue XXII is a plant biotech company and should easily command a 200-400 million valuation+, relative to peers at this moment. Sorry Gary, I don't see your argument here.

In addition, many of us bought into the stock based on the Modified risk sales potential. Red Sun was a bonus to get us on the revenue board. SF Private label should cover overhead based on what I heard from Henry. I see minimal risk from here when you consider the IP value for Tobacco and MJ. The market puts a valuation on these things.

It's too bad the stock got ahead of itself and flew to 6.36. This attracted the flies (shorts and other detractors) and We have been left with over exaggerations both to the up and downside (margin calls, stop losses heavy shorting). I'm 99.9 percent confident that we wouldn't have witnessed a free fall if the stock didn't get ahead of itself to begin with.